Page last updated: 2024-09-02

2,3-bis(3'-hydroxybenzyl)butyrolactone and cytochrome c-t

2,3-bis(3'-hydroxybenzyl)butyrolactone has been researched along with cytochrome c-t in 1 studies

Compound Research Comparison

Studies
(2,3-bis(3'-hydroxybenzyl)butyrolactone)
Trials
(2,3-bis(3'-hydroxybenzyl)butyrolactone)
Recent Studies (post-2010)
(2,3-bis(3'-hydroxybenzyl)butyrolactone)
Studies
(cytochrome c-t)
Trials
(cytochrome c-t)
Recent Studies (post-2010) (cytochrome c-t)
3193212411,809215,125

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, LH; Demark-Wahnefried, W; Fang, J; Li, H; Lin, X1

Other Studies

1 other study(ies) available for 2,3-bis(3'-hydroxybenzyl)butyrolactone and cytochrome c-t

ArticleYear
Enterolactone induces apoptosis in human prostate carcinoma LNCaP cells via a mitochondrial-mediated, caspase-dependent pathway.
    Molecular cancer therapeutics, 2007, Volume: 6, Issue:9

    Topics: 4-Butyrolactone; Apoptosis; Caspases; Cell Survival; Cytochromes c; Enzyme Activation; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Immunoblotting; In Situ Nick-End Labeling; Lignans; Male; Membrane Potential, Mitochondrial; Mitochondria; Phytoestrogens; Poly(ADP-ribose) Polymerases; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-mdm2; Tumor Cells, Cultured; Tumor Suppressor Protein p53

2007